Cellebrite Capex To Revenue vs Ebit Per Revenue Analysis

CLBT Stock

USD 19.72 0.46 2.28%

Cellebrite financial indicator trend analysis is way more than just evaluating Cellebrite DI prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cellebrite DI is a good investment. Please check the relationship between Cellebrite Capex To Revenue and its Ebit Per Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellebrite DI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Capex To Revenue vs Ebit Per Revenue

Capex To Revenue vs Ebit Per Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cellebrite DI Capex To Revenue account and Ebit Per Revenue. At this time, the significance of the direction appears to have pay attention.

The correlation between Cellebrite's Capex To Revenue and Ebit Per Revenue is -0.73. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Ebit Per Revenue in the same time period over historical financial statements of Cellebrite DI, assuming nothing else is changed. The correlation between historical values of Cellebrite's Capex To Revenue and Ebit Per Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Cellebrite DI are associated (or correlated) with its Ebit Per Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit Per Revenue has no effect on the direction of Capex To Revenue i.e., Cellebrite's Capex To Revenue and Ebit Per Revenue go up and down completely randomly.

Correlation Coefficient

-0.73

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Ebit Per Revenue

Most indicators from Cellebrite's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cellebrite DI current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellebrite DI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Sales General And Administrative To Revenue is likely to gain to 0.18 in 2024, whereas Tax Provision is likely to drop slightly above 4 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	7.0M	9.2M	10.0M	8.0M
Interest Income	68.5M	1.6M	8.9M	8.4M

Depreciation And Amortization Interest Income

Cellebrite fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		0.83	0.96	-0.24	0.64	-0.27	0.87	0.98	-0.81	0.73	0.53	0.89	0.95	0.85	0.93	0.8	0.9	-0.07	-0.4	0.79	0.92	0.93	-0.32	0.93	-0.24	0.95
Other Current Liab	0.83		0.94	-0.53	0.85	-0.63	0.72	0.89	-0.82	0.71	0.59	0.85	0.87	0.63	0.92	0.46	0.97	-0.42	-0.78	0.76	0.82	0.96	-0.63	0.9	-0.53	0.74
Total Current Liabilities	0.96	0.94		-0.42	0.81	-0.49	0.88	0.99	-0.81	0.82	0.61	0.89	0.98	0.77	0.99	0.62	0.98	-0.15	-0.62	0.82	0.95	0.99	-0.56	0.96	-0.42	0.89
Total Stockholder Equity	-0.24	-0.53	-0.42		-0.84	0.96	-0.05	-0.34	0.58	-0.16	-0.9	-0.57	-0.33	-0.27	-0.43	0.01	-0.37	0.25	0.88	-0.73	-0.26	-0.37	0.75	-0.58	1.0	-0.39
Other Liab	0.64	0.85	0.81	-0.84		-0.9	0.57	0.76	-0.71	0.65	0.84	0.76	0.77	0.51	0.83	0.2	0.79	-0.18	-0.92	0.83	0.73	0.79	-0.89	0.86	-0.84	0.66
Net Tangible Assets	-0.27	-0.63	-0.49	0.96	-0.9		-0.17	-0.41	0.5	-0.32	-0.81	-0.55	-0.42	-0.17	-0.53	0.1	-0.48	0.32	0.92	-0.67	-0.36	-0.48	0.88	-0.6	0.96	-0.36
Property Plant And Equipment Net	0.87	0.72	0.88	-0.05	0.57	-0.17		0.91	-0.5	0.95	0.28	0.58	0.95	0.67	0.89	0.48	0.87	0.21	-0.34	0.51	0.97	0.88	-0.45	0.75	-0.05	0.72
Current Deferred Revenue	0.98	0.89	0.99	-0.34	0.76	-0.41	0.91		-0.78	0.83	0.58	0.87	0.99	0.8	0.98	0.66	0.95	-0.06	-0.53	0.8	0.97	0.97	-0.5	0.95	-0.34	0.91
Net Debt	-0.81	-0.82	-0.81	0.58	-0.71	0.5	-0.5	-0.78		-0.38	-0.76	-0.94	-0.7	-0.87	-0.72	-0.73	-0.76	0.31	0.64	-0.9	-0.64	-0.76	0.31	-0.89	0.58	-0.85
Retained Earnings	0.73	0.71	0.82	-0.16	0.65	-0.32	0.95	0.83	-0.38		0.28	0.46	0.9	0.51	0.86	0.21	0.84	0.22	-0.48	0.43	0.93	0.83	-0.65	0.68	-0.16	0.56
Accounts Payable	0.53	0.59	0.61	-0.9	0.84	-0.81	0.28	0.58	-0.76	0.28		0.78	0.54	0.6	0.59	0.36	0.5	-0.07	-0.75	0.93	0.48	0.53	-0.61	0.79	-0.9	0.71
Cash	0.89	0.85	0.89	-0.57	0.76	-0.55	0.58	0.87	-0.94	0.46	0.78		0.79	0.79	0.84	0.77	0.81	-0.34	-0.59	0.95	0.73	0.85	-0.38	0.96	-0.57	0.94
Non Current Assets Total	0.95	0.87	0.98	-0.33	0.77	-0.42	0.95	0.99	-0.7	0.9	0.54	0.79		0.74	0.99	0.56	0.95	0.02	-0.54	0.74	0.99	0.97	-0.57	0.92	-0.33	0.86
Non Currrent Assets Other	0.85	0.63	0.77	-0.27	0.51	-0.17	0.67	0.8	-0.87	0.51	0.6	0.79	0.74		0.69	0.8	0.69	0.15	-0.36	0.77	0.73	0.7	-0.14	0.81	-0.27	0.87
Other Assets	0.93	0.92	0.99	-0.43	0.83	-0.53	0.89	0.98	-0.72	0.86	0.59	0.84	0.99	0.69		0.53	0.97	-0.12	-0.63	0.78	0.96	0.99	-0.64	0.94	-0.43	0.85
Cash And Short Term Investments	0.8	0.46	0.62	0.01	0.2	0.1	0.48	0.66	-0.73	0.21	0.36	0.77	0.56	0.8	0.53		0.51	-0.12	0.03	0.65	0.52	0.56	0.25	0.66	0.01	0.85
Net Receivables	0.9	0.97	0.98	-0.37	0.79	-0.48	0.87	0.95	-0.76	0.84	0.5	0.81	0.95	0.69	0.97	0.51		-0.24	-0.66	0.71	0.93	0.99	-0.59	0.9	-0.37	0.78
Common Stock Shares Outstanding	-0.07	-0.42	-0.15	0.25	-0.18	0.32	0.21	-0.06	0.31	0.22	-0.07	-0.34	0.02	0.15	-0.12	-0.12	-0.24		0.31	-0.16	0.11	-0.23	0.04	-0.16	0.25	-0.03
Short Term Investments	-0.4	-0.78	-0.62	0.88	-0.92	0.92	-0.34	-0.53	0.64	-0.48	-0.75	-0.59	-0.54	-0.36	-0.63	0.03	-0.66	0.31		-0.66	-0.5	-0.62	0.87	-0.67	0.88	-0.4
Non Current Liabilities Total	0.79	0.76	0.82	-0.73	0.83	-0.67	0.51	0.8	-0.9	0.43	0.93	0.95	0.74	0.77	0.78	0.65	0.71	-0.16	-0.66		0.68	0.75	-0.5	0.94	-0.73	0.91
Inventory	0.92	0.82	0.95	-0.26	0.73	-0.36	0.97	0.97	-0.64	0.93	0.48	0.73	0.99	0.73	0.96	0.52	0.93	0.11	-0.5	0.68		0.94	-0.56	0.87	-0.26	0.82
Other Current Assets	0.93	0.96	0.99	-0.37	0.79	-0.48	0.88	0.97	-0.76	0.83	0.53	0.85	0.97	0.7	0.99	0.56	0.99	-0.23	-0.62	0.75	0.94		-0.57	0.93	-0.37	0.83
Other Stockholder Equity	-0.32	-0.63	-0.56	0.75	-0.89	0.88	-0.45	-0.5	0.31	-0.65	-0.61	-0.38	-0.57	-0.14	-0.64	0.25	-0.59	0.04	0.87	-0.5	-0.56	-0.57		-0.56	0.75	-0.29
Total Liab	0.93	0.9	0.96	-0.58	0.86	-0.6	0.75	0.95	-0.89	0.68	0.79	0.96	0.92	0.81	0.94	0.66	0.9	-0.16	-0.67	0.94	0.87	0.93	-0.56		-0.58	0.94
Net Invested Capital	-0.24	-0.53	-0.42	1.0	-0.84	0.96	-0.05	-0.34	0.58	-0.16	-0.9	-0.57	-0.33	-0.27	-0.43	0.01	-0.37	0.25	0.88	-0.73	-0.26	-0.37	0.75	-0.58		-0.39
Property Plant And Equipment Gross	0.95	0.74	0.89	-0.39	0.66	-0.36	0.72	0.91	-0.85	0.56	0.71	0.94	0.86	0.87	0.85	0.85	0.78	-0.03	-0.4	0.91	0.82	0.83	-0.29	0.94	-0.39

Click cells to compare fundamentals

Cellebrite Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Cellebrite Stock Analysis

When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cellebrite Capex To Revenue vs Ebit Per Revenue Analysis

Capex To Revenue vs Ebit Per Revenue

Capex To Revenue vs Ebit Per Revenue Correlation Analysis

Correlation Coefficient

Capex To Revenue

Ebit Per Revenue

Cellebrite fundamental ratios Correlations

Cellebrite Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Cellebrite Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Total Stockholder Equity
Current Deferred Revenue	+ 0.99	Total Current Liabilities
Other Assets	+ 0.99	Total Current Liabilities
Other Current Assets	+ 0.99	Total Current Liabilities
Non Current Assets Total	+ 0.99	Current Deferred Revenue
Other Assets	+ 0.99	Non Current Assets Total

Cash	- 0.94	Net Debt
Short Term Investments	- 0.92	Other Liab
Net Invested Capital	- 0.9	Accounts Payable
Non Current Liabilities Total	- 0.9	Net Debt
Net Tangible Assets	- 0.9	Other Liab
Accounts Payable	- 0.9	Total Stockholder Equity